2/6
08:03 am
tvtx
Travere Therapeutics (NASDAQ:TVTX) had its "neutral" rating reaffirmed by analysts at Piper Sandler.
Low
Report
Travere Therapeutics (NASDAQ:TVTX) had its "neutral" rating reaffirmed by analysts at Piper Sandler.
2/4
05:05 pm
tvtx
Travere Therapeutics to Present at the Guggenheim Emerging Outlook Biotech Summit [Yahoo! Finance]
Medium
Report
Travere Therapeutics to Present at the Guggenheim Emerging Outlook Biotech Summit [Yahoo! Finance]
2/4
04:30 pm
tvtx
Travere Therapeutics to Present at the Guggenheim Emerging Outlook Biotech Summit
Medium
Report
Travere Therapeutics to Present at the Guggenheim Emerging Outlook Biotech Summit
2/2
01:33 am
tvtx
Is Travere Therapeutics (TVTX) Facing a Credibility Test in Its Disclosure and Risk Narrative? [Yahoo! Finance]
Medium
Report
Is Travere Therapeutics (TVTX) Facing a Credibility Test in Its Disclosure and Risk Narrative? [Yahoo! Finance]
1/30
08:50 pm
tvtx
TVTX ALERT: Investigation Launched into Travere Therapeutics, Inc., Robbins Geller Rudman & Dowd LLP Encourages Investors and Potential Witnesses to Contact Law Firm
Medium
Report
TVTX ALERT: Investigation Launched into Travere Therapeutics, Inc., Robbins Geller Rudman & Dowd LLP Encourages Investors and Potential Witnesses to Contact Law Firm
1/29
12:01 pm
tvtx
Travere Therapeutics: Filspari's FSGS Approval Chance Is Higher Than You Think [Seeking Alpha]
Low
Report
Travere Therapeutics: Filspari's FSGS Approval Chance Is Higher Than You Think [Seeking Alpha]
1/28
07:10 am
tvtx
TVTX INVESTIGATION NOTICE: Robbins Geller Rudman & Dowd LLP Launches Investigation into Travere Therapeutics, Inc., and Encourages Investors and Potential Witnesses to Contact Law Firm
Low
Report
TVTX INVESTIGATION NOTICE: Robbins Geller Rudman & Dowd LLP Launches Investigation into Travere Therapeutics, Inc., and Encourages Investors and Potential Witnesses to Contact Law Firm
1/27
07:54 am
tvtx
TVTX: Travere Therapeutics Shareholders Should Contact Block & Leviton To Potentially Recover Losses
Low
Report
TVTX: Travere Therapeutics Shareholders Should Contact Block & Leviton To Potentially Recover Losses
1/24
04:36 pm
tvtx
Palisades Investment Initiated a Position in Travere Therapeutics Worth Over $5 Million. Is the Stock a Buy? [Yahoo! Finance]
Medium
Report
Palisades Investment Initiated a Position in Travere Therapeutics Worth Over $5 Million. Is the Stock a Buy? [Yahoo! Finance]
1/24
02:26 am
tvtx
BofA Remains Positive on Travere Despite FDA Decision Delay for Filspari [Yahoo! Finance]
Medium
Report
BofA Remains Positive on Travere Despite FDA Decision Delay for Filspari [Yahoo! Finance]
1/16
06:00 am
tvtx
TVTX INVESTIGATION ALERT: Robbins Geller Rudman & Dowd LLP Launches Investigation into Travere Therapeutics, Inc., and Encourages Investors and Potential Witnesses to Contact Law Firm
Low
Report
TVTX INVESTIGATION ALERT: Robbins Geller Rudman & Dowd LLP Launches Investigation into Travere Therapeutics, Inc., and Encourages Investors and Potential Witnesses to Contact Law Firm
1/15
08:14 am
tvtx
Travere Therapeutics 2026 Outlook: Filspari Momentum, FSGS FDA Delay, And Market Potential [Seeking Alpha]
Low
Report
Travere Therapeutics 2026 Outlook: Filspari Momentum, FSGS FDA Delay, And Market Potential [Seeking Alpha]
1/14
05:26 pm
tvtx
Is Travere Therapeutics (TVTX) Pricing Reflect Long Term Value After Recent Share Price Pullback [Yahoo! Finance]
Low
Report
Is Travere Therapeutics (TVTX) Pricing Reflect Long Term Value After Recent Share Price Pullback [Yahoo! Finance]
1/14
04:04 pm
tvtx
INVESTOR ALERT: Investigation of Travere Therapeutics, Inc. (TVTX) by Holzer & Holzer, LLC
Low
Report
INVESTOR ALERT: Investigation of Travere Therapeutics, Inc. (TVTX) by Holzer & Holzer, LLC
1/14
12:13 pm
tvtx
TVTX Stock Falls as FDA Extends Review Timeline for Filspari sNDA [Yahoo! Finance]
Low
Report
TVTX Stock Falls as FDA Extends Review Timeline for Filspari sNDA [Yahoo! Finance]
1/14
08:42 am
tvtx
Travere Therapeutics (NASDAQ:TVTX) had its "buy" rating reaffirmed by analysts at Guggenheim.
Low
Report
Travere Therapeutics (NASDAQ:TVTX) had its "buy" rating reaffirmed by analysts at Guggenheim.
1/13
08:21 pm
tvtx
Why Travere Therapeutics Stock Got Trounced on Tuesday [Yahoo! Finance]
Low
Report
Why Travere Therapeutics Stock Got Trounced on Tuesday [Yahoo! Finance]
1/13
06:58 pm
tvtx
TVTX ALERT: Investigation Launched into Travere Therapeutics, Inc., RGRD Law Attorneys Encourage Investors and Potential Witnesses to Contact Law Firm
Low
Report
TVTX ALERT: Investigation Launched into Travere Therapeutics, Inc., RGRD Law Attorneys Encourage Investors and Potential Witnesses to Contact Law Firm
1/13
03:05 pm
tvtx
SHAREHOLDER ALERT: Travere Therapeutics, Inc. Investigated for Securities Fraud by Block & Leviton; Investors Who Lost Money Should Contact The Firm
Medium
Report
SHAREHOLDER ALERT: Travere Therapeutics, Inc. Investigated for Securities Fraud by Block & Leviton; Investors Who Lost Money Should Contact The Firm
1/13
02:19 pm
tvtx
Travere Therapeutics Announces FDA Extends Review of sNDA for FILSPARI® (sparsentan) in FSGS [Yahoo! Finance]
Medium
Report
Travere Therapeutics Announces FDA Extends Review of sNDA for FILSPARI® (sparsentan) in FSGS [Yahoo! Finance]
1/13
02:18 pm
tvtx
Top Midday Decliners [Yahoo! Finance]
Medium
Report
Top Midday Decliners [Yahoo! Finance]
1/13
01:24 pm
tvtx
Travere Therapeutics Announces FDA Extends Review of sNDA for FILSPARI® (sparsentan) in FSGS
High
Report
Travere Therapeutics Announces FDA Extends Review of sNDA for FILSPARI® (sparsentan) in FSGS
1/12
05:00 pm
tvtx
Travere Therapeutics Provides Corporate Update and 2026 Outlook
High
Report
Travere Therapeutics Provides Corporate Update and 2026 Outlook
1/5
05:03 pm
tvtx
Travere Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
Medium
Report
Travere Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
1/5
04:30 pm
tvtx
Travere Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
Medium
Report
Travere Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference